http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103211822-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2012-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103211822-B |
| titleOfInvention | A kind of purposes of the suppression lipase of sterol derivative |
| abstract | The invention belongs to field of medicine and chemical technology, it is related to a kind of purposes of the suppression lipase of sterol derivative.Wherein, the sterol derivative is the compound shown in Formulas I, or its pharmaceutically acceptable salt, wherein, R 1 Selected from OH ,=O, H and C 1 ‑C 3 Alkyl；R 2 Selected from OH, H and C 1 ‑C 3 Alkyl；R 3 Selected from OH ,=O, H and C 1 ‑C 3 Alkyl；R 4 Selected from OH, H and C 1 ‑C 3 Alkyl；And R 1 、R 2 、R 3 And R 4 In any 2,3 or 4 simultaneously for OH.The compound of the present invention can effectively suppress lipase, and inhibitory action and in concentration effect relation；So as to the potentiality as prevention and/or the medicine or slimming medicine for the treatment of and/or auxiliary treatment obesity or obesity-related disorder. |
| priorityDate | 2012-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.